Trump Administration Nixes Plan to Cover Anti-Obesity Drugs Through MedicareTrump's administration ruled out coverage for high-demand obesity treatments under Medicare.
Europe's most valuable company Novo Nordisk reports a slight increase in profitsNovo Nordisk posted a slight increase in net profit for the second quarter and raised its forecast for the full year due to increased demand for its diabetes and obesity treatments.
Novo Nordisk (NVO) Price Prediction and Forecast 2025-2030 (March 2025)Ozempic's sales surge has significantly boosted Novo Nordisk's market value, reflecting the drug's unexpected profitability as a weight-loss treatment.
Europe's most valuable company Novo Nordisk reports a slight increase in profitsNovo Nordisk posted a slight increase in net profit for the second quarter and raised its forecast for the full year due to increased demand for its diabetes and obesity treatments.
Novo Nordisk (NVO) Price Prediction and Forecast 2025-2030 (March 2025)Ozempic's sales surge has significantly boosted Novo Nordisk's market value, reflecting the drug's unexpected profitability as a weight-loss treatment.
When online weight-loss drugs are too good to be trueZappy Health's low-cost obesity drugs were sourced from an unlicensed pharmacy, leading to significant customer and company fallout.
Joel Habener, Dan Drucker, Svetlana Mojsov and Jens Juul HolstGLP-1 research by Holst, Habener, Mojsov, Drucker led to revolutionary weight-loss drugs.